Ergoteles LLC Editas Medicine, Inc. Transaction History

Ergoteles LLC

  • $68.2 Billion
  • Q3 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$9.99 - $21.35 $508,990 - $1.09 Million
-50,950 Closed
0 $0
Q1 2022

May 13, 2022
BUY
$14.08 - $27.63 $558,680 - $1.1 Million
39,679 Added 352.05%
50,950 $969,000
Q4 2021

Feb 14, 2022
BUY
$26.55 - $40.57 $299,245 - $457,264
11,271 New
11,271 $299,000

Others Institutions Holding EDIT

# of Institutions
252
Shares Held
58.7M
Call Options Held
494K
Put Options Held
417K
View Full List

About Editas Medicine, Inc.

EDIT Quotes by TradingView
  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $234M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Ergoteles LLC Portfolio

Follow Ergoteles LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ergoteles LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email